v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 8 Months Ended 12 Months Ended
Dec. 31, 2025
Apr. 30, 2025
Apr. 30, 2024
Income Statement [Abstract]      
Product revenue, net $ 49,078,000    
Operating expenses:      
Cost of revenue 3,081,000    
Research and development 33,371,000 $ 71,709,000 $ 86,167,000
Selling, general and administrative 124,663,000 116,286,000 54,278,000
Total operating expenses 161,115,000 187,995,000 140,445,000
Operating loss (112,037,000) (187,995,000) (140,445,000)
Other (expense) income:      
Interest income 5,789,000 6,435,000 3,896,000
Interest expense (12,895,000) (5,785,000)  
Foreign currency exchange gain 30,000 2,481,000 138,000
Other income, net 8,556,000 4,812,000 9,767,000
Total other income 1,480,000 7,943,000 13,801,000
Loss before income tax (benefit) expense (110,557,000) (180,052,000) (126,644,000)
Income tax (benefit) expense (1,033,000) 3,392,000 0
Net loss (109,524,000) (183,444,000) (126,644,000)
Other comprehensive (loss) income:      
Foreign currency translation loss (1,004,000) (2,523,000) (394,000)
Unrealized holding gain on marketable securities 316,000 2,358,000 1,291,000
Reclassification adjustment for realized holding gain on marketable securities included in net loss (1,227,000) (1,561,000) (1,325,000)
Total other comprehensive (loss) (1,915,000) (1,726,000) (428,000)
Comprehensive loss $ (111,439,000) $ (185,170,000) $ (127,072,000)
Weighted average shares outstanding, basic 53,870,007 49,652,878 36,786,575
Weighted average shares outstanding, diluted 53,870,007 49,652,878 36,786,575
Net loss per share, basic $ (2.03) $ (3.69) $ (3.44)
Net loss per share, diluted $ (2.03) $ (3.69) $ (3.44)